Relief Therapeutics sees 60-70% chance of COVID-19 drug approval

Relief Therapeutics' chairman said he was optimistic its RLF100 (aviptadil) drug will win approval for treating COVID19 patients in a matter of months.

from Top Business News- News18.com https://ift.tt/3iiMtAb